Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vitamin D-dependent induction of cathelicidin in human macrophages results in cytotoxicity against high-grade B cell lymphoma.
Bruns H, Büttner M, Fabri M, Mougiakakos D, Bittenbring JT, Hoffmann MH, Beier F, Pasemann S, Jitschin R, Hofmann AD, Neumann F, Daniel C, Maurberger A, Kempkes B, Amann K, Mackensen A, Gerbitz A. Bruns H, et al. Among authors: neumann f. Sci Transl Med. 2015 Apr 8;7(282):282ra47. doi: 10.1126/scitranslmed.aaa3230. Sci Transl Med. 2015. PMID: 25855493
Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab.
Bittenbring JT, Neumann F, Altmann B, Achenbach M, Reichrath J, Ziepert M, Geisel J, Regitz E, Held G, Pfreundschuh M. Bittenbring JT, et al. Among authors: neumann f. J Clin Oncol. 2014 Oct 10;32(29):3242-8. doi: 10.1200/JCO.2013.53.4537. Epub 2014 Aug 18. J Clin Oncol. 2014. PMID: 25135997 Clinical Trial.
Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway.
Busch L, Mougiakakos D, Büttner-Herold M, Müller MJ, Volmer DA, Bach C, Fabri M, Bittenbring JT, Neumann F, Boxhammer R, Nolting J, Bisht S, Böttcher M, Jitschin S, Hoffmann MH, Balzer H, Beier F, Gezer D, Dudziak D, Gelse K, Hennig FF, Pallasch CP, Spriewald B, Mackensen A, Bruns H. Busch L, et al. Among authors: neumann f. Leukemia. 2018 Nov;32(11):2445-2458. doi: 10.1038/s41375-018-0114-0. Epub 2018 Mar 28. Leukemia. 2018. PMID: 29654274
Vitamin D deficiency in head and neck cancer patients - prevalence, prognostic value and impact on immune function.
Bochen F, Balensiefer B, Körner S, Bittenbring JT, Neumann F, Koch A, Bumm K, Marx A, Wemmert S, Papaspyrou G, Zuschlag D, Kühn JP, Al Kadah B, Schick B, Linxweiler M. Bochen F, et al. Among authors: neumann f. Oncoimmunology. 2018 Jul 23;7(9):e1476817. doi: 10.1080/2162402X.2018.1476817. eCollection 2018. Oncoimmunology. 2018. PMID: 30228945 Free PMC article.
β2-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression.
Hofbauer D, Mougiakakos D, Broggini L, Zaiss M, Büttner-Herold M, Bach C, Spriewald B, Neumann F, Bisht S, Nolting J, Zeiser R, Hamarsheh S, Eberhardt M, Vera J, Visentin C, De Luca CMG, Moda F, Haskamp S, Flamann C, Böttcher M, Bitterer K, Völkl S, Mackensen A, Ricagno S, Bruns H. Hofbauer D, et al. Among authors: neumann f. Immunity. 2021 Aug 10;54(8):1772-1787.e9. doi: 10.1016/j.immuni.2021.07.002. Epub 2021 Jul 20. Immunity. 2021. PMID: 34289378 Free article.
Differential effects of endurance, interval, and resistance training on telomerase activity and telomere length in a randomized, controlled study.
Werner CM, Hecksteden A, Morsch A, Zundler J, Wegmann M, Kratzsch J, Thiery J, Hohl M, Bittenbring JT, Neumann F, Böhm M, Meyer T, Laufs U. Werner CM, et al. Among authors: neumann f. Eur Heart J. 2019 Jan 1;40(1):34-46. doi: 10.1093/eurheartj/ehy585. Eur Heart J. 2019. PMID: 30496493 Free PMC article. Clinical Trial.
CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patients.
Zöphel S, Küchler N, Jansky J, Hoxha C, Schäfer G, Weise JJ, Vialle J, Kaschek L, Stopper G, Eichler H, Yildiz D, Moter A, Wendel P, Ullrich E, Schormann C, Rixecker T, Cetin O, Neumann F, Orth P, Bewarder M, Hoth M, Thurner L, Schwarz EC. Zöphel S, et al. Among authors: neumann f. Mol Cancer. 2024 Sep 28;23(1):210. doi: 10.1186/s12943-024-02123-7. Mol Cancer. 2024. PMID: 39342291 Free PMC article.
1,234 results